Phase II study of extended-dose temozolomide in patients with melanoma.
Rietschel P, Wolchok JD, Krown S, Gerst S, Jungbluth AA, Busam K, Smith K, Orlow I, Panageas K, Chapman PB.
Rietschel P, et al. Among authors: busam k.
J Clin Oncol. 2008 May 10;26(14):2299-304. doi: 10.1200/JCO.2007.14.5292.
J Clin Oncol. 2008.
PMID: 18467721
Clinical Trial.